Eighteen cases of culture positive melioidosis caused by Burkholderia pseudomallei, were seen in four geographically separate communities in North Queensland, Australia. The genetic inter-relatedness of the clinical isolates were compared utilising random amplification of polymorphic DNA (RAPD) and multilocus enzyme electrophoresis (MEE). The isolates segregated into two groups that correlated with clinical presentation rather than geographical location. This is the first described association between the varied clinical presentations of this condition and specific molecular type. If proven on larger studies, this may further our understanding of the pathogenesis of this important condition. z 1998 Federation of European Microbiological Societies. Published by Elsevier Science B.V.
Introduction
Burkholderia pseudomallei, the causative agent of melioidosis is a saprophyte found in the soil in endemic areas. Both man and animals are thought to contract the infection by inoculation, inhalation or ingestion of this environmental organism in contaminated soil or water [1, 2] .
Regional endemic foci of this disease are largely con¢ned to South-East Asia and tropical Australia between latitudes 20³S and 20³N, although the organism has been isolated in sub-tropical South-West Australia [3, 4] . In many endemic areas, the frequency of the disease varies greatly with time. It is hypothesised that the increased incidence of melioidosis after heavy rains is a consequence of the organism being brought up to the surface by the rising watertable from the deeper moist layers of clay where it is thought to persist during the dry season [5] . Most people exposed to the organism do not develop clinical disease. The organism may however remain dormant intracellularly for long periods and give rise to disease after a long latent period. This occurrence was well described in US veterans who returned home after the Vietnam war [6] . While recognised risk factors for clinical disease include diabetes, alcohol abuse, and immuno-compromised patients, it should be noted that fulminant infection may occur in previously healthy individuals.
A classi¢cation system for melioidosis was proposed with ¢ve categories. These are disseminated septicaemic, non-disseminated septicaemic, localised, transient bacteraemic and probable infection. This last category is based on serological ¢ndings. The disseminated septicaemic group account for 45% of cases with a mortality of 87%. Non-disseminated septicaemic disease is seen in 12% of cases with a mortality of 17% and localised disease accounts for 42% of cases with a mortality of 9% [7] .
The clinical presentations of patients with melioidosis usually fall into one of the categories described. There is the chronic asymptomatic infection referred to above, characterised by abnormal serology and which can occasionally progress. In endemic areas, patients may present with an acute localised skin infection at the site of inoculation of the organism usually with an accompanying regional lymphadenitis. The most dramatic presentation is of an acute septicaemic illness which may be associated with one or more foci of visceral involvement, pneumonia being the most frequent. This septicaemic, pneumonic presentation has been speci¢cally reported in one study to have a fatality rate of up to 75% [1] . Finally patients may present with chronic suppuration and abscess formation. A wide number of organs and tissues including lung, pancreas, spleen, prostate, testis, kidney, brain and bone, may be involved in melioidosis. This may occur either acutely with a septicaemic presentation, or chronically after inapparent infection or as a relapse after a previous septicaemic presentation. The mechanisms underlying the di¡erent manifestations of this disease and the factors that determine which tissues and organs are involved are poorly understood.
Materials and methods
This paper is based on isolates from eighteen cases of culture proven melioidosis which were diagnosed through the laboratory at Townsville General Hos- pital. The majority of these were admitted to the hospital which serves as a tertiary referral centre for North Queensland. They demonstrate the diversity of clinical presentations of this condition. These cases occurred in four geographically distinct communities in North Queensland. All cases came from four communities (A^D). These communities were up to 1000 km apart, one being an island community from which eight of the cases came. Details are provided in Table 1 . The appearance of these cases over a six-month period coincided with a period of heavy rainfall in the region. For three years before, during which time there had been failures of the wet season, no acute cases of melioidosis were seen in the hospital. The initial aim of the study was to explore whether there was any evidence of relatedness between strains isolated from patients living in the di¡erent geographical areas. Isolates were typed by random ampli¢ca-tion of polymorphic DNA (RAPD) and multi-locus enzyme electrophoresis (MEE).
Cases
A case was de¢ned as one in which B. pseudomallei was isolated from clinical material, e.g. blood, sputum, pus, pleural £uid and post-mortem brain. All eighteen cases demonstrated clinical evidence of sepsis. There were seven cases of acute septicaemia with pneumonia, two of brain stem encephalitis, four with pancreatic or hepatosplenic abscesses, three with septic arthritis or osteomyelitis, one with a soft tissue infection and one septicaemic illness of unknown origin.
Bacterial isolation and identi¢cation
All isolates were presumptively identi¢ed by their characteristic colonial morphology, growth on Ashdown's agar (Oxoid) and gentamicin resistance. These were con¢rmed by the API-20 NE (Bio-Merieux).
Typing of bacterial isolates
A total of eighteen isolates were typed by RAPD PCR analysis and 12 isolates were typed by multilocus enzyme electrophoresis (MEE).
Chromosomal DNA preparation for RAPD typing
All bacteria were cultured on Ashdown's agar and sub-cultured in £asks containing 100 ml tryptone soy broth at 37³C overnight in a shaking incubator. The cultures were centrifuged in small aliquots at 10 000Ug for 60 min and the cell pellets were resuspended in 570 Wl TE bu¡er, pH 8.0, containing 3 Wl of 20 mg ml 3I Proteinase K and 30 Wl of 10% (w/v) SDS. The samples were incubated at 37³C for 60 min, and 100 Wl of 5 M NaCl was added, and the contents mixed thoroughly. A volume of 80 Wl of 10% hexadecyl trimethyl ammonium bromide (CTAB)/0.7 M NaCl solution was added, the contents were mixed and incubated at 65³C for 30 min. An equal volume of chloroform/isoamyl alcohol (24:1) was added, the contents mixed and microcentrifuged for 5 min. The supernatant £uid was transferred to a fresh tube and an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) was added. The tubes were again centrifuged for 5 min and the supernatant £uid transferred to a fresh tube. Isopropanol to a ¢nal concentration of 0.6 total volume was added, the tubes centrifuged, and the pellets were washed, dried, and resuspended in 50 Wl TE bu¡er. All DNA samples were stored at 4³C until analysed.
Selection of primers
A commercially available Arbitary Priming Fingerprinting kit containing a set of 20 random 10-base oligonucleotide primers was used for RAPD typing (Bresatec, Adelaide, Australia). Each primer was tested singly with the 18 DNA samples and eight primers found to produce the best discrimination between samples were selected for all further studies.
RAPD PCR
Ampli¢cation was performed in a total volume of 25 Wl containing 50 pmol of each primer, 2.5 mM MgCl P , 200 WM each dNTP, 2 U Taq polymerase in PCR bu¡er (Bresatec, Adelaide). The reaction mix was overlaid with 20 Wl mineral oil, and incubated for 5 min at 94³C. The reaction pro¢le performed in a programmable thermal cycler (Brestaec, Adelaide) consisted of 5 cycles of 1 min at 95³C, 2 min at 35³C, and 2 min at 72³C. This was followed by a further 35 cycles of 1 min at 95³C, 1 min at 35³C, and 1 min at 72³C. A ¢nal extension step of 5 min at 72³C was included, and the tubes were stored at 4³C until further analysis.
Detection of ampli¢ed products
The products were visualised by ethidium bromide staining following electrophoresis on a 1.5% (w/v) agarose gel in 0.5UTBE bu¡er (45 mM Tris-borate/1 mM EDTA bu¡er at 5 V cm 3I . In addition, products were electrophoresed on a 8% (w/v) polyacrylamide gel at 3 V cm 3I and detected by staining with ethidium bromide and UV transillumination.
Analysis of banding pro¢les
All banding pro¢les were converted into matrices where`1' represented the presence of a particular band, and`0' represented its absence. One matrix was produced for each set of samples with each of the 8 selected primers. The data generated from these tables was analysed using the RAPDistance computer software package (Armstrong et al., Australian National University, Canberra, Australia).
Sample preparation for MEE
Isolates 1^12 were streaked onto tryptone soy agar containing yeast extract to enable isolation of single colonies. After incubation at 37³C for 24 h, a single colony was selected and inoculated into 100 ml brain heart infusion broth. The £asks were incubated with shaking at 37³C for 24 h, at which time they were centrifuged at 5000Ug for 30 min. The supernatant £uid was discarded, and the pellets were resuspended in 1.2 ml of breaking bu¡er (10 mM Tris, pH 6.8, 1 mM EDTA, 0.5 mM NADP). The suspensions were frozen and ground with a mortar and pestle on dry ice, until a ¢ne white powder resulted. The powder was allowed to liquefy at room temperature, and then centrifuged at 9000Ug for 5 min at 4³C in a microfuge. The supernatant £uid (clari¢ed cell lysate) was removed from the pellet (whole cells and cell wall fractions) and stored in 60 Wl aliquots at 320³C until required.
Electrophoresis and gel staining
For each of the 12 cell lysates, the electrophoretic mobility of 10 di¡erent enzymes was determined by the procedure of Selander et al. [8] , and modi¢ed by Sutherland and Porritt [9] . Catalase activity was assayed by the method of Harris and Hopkinson [10] . Cell lysates were subjected to horizontal electrophoresis at 130 V in 11.4% (w/v) starch gels containing either Tris/citrate bu¡er, pH 8.0, or Tris/maleate bu¡er, pH 8.2. Electrophoresis was continued for 4 h or until a marker (0.1% bromophenol blue) had migrated to approximately 1 cm from the anodal end of the gel. Each gel was sliced horizontally, to yield 4 slices, each approximately 2 mm thick. The slices were stained separately for speci¢c enzymatic activity.
Analysis of MEE data
Analysis of the data was carried out with a computer program described by Selander et al. [8] , and obtained from the author, T.S. Whittam (Penn. State University). The program calculates the genetic diversity for each enzyme locus among the electrophoretic types (ETs), and the genetic distance between ETs is expressed as a proportion of the loci at which dissimilar`alleles' occurred, with the contribution of each locus weighted by the genetic diversity at the locus. The clustering of the ETs was produced using the average-linkage method from a matrix of coe¤-cients of pair-wise genetic distances.
Results

RAPD analysis
A total of 20 arbitrary primers were tested with each of the 18 DNA samples. All were found to give some degree of discrimination between samples. A series of 8 primers found to produce the highest number of discriminatory bands, were used to produce the banding pro¢les subsequently analysed in a RAPD distance program. All isolates showed di¡er-ent banding patterns with this set of primers. Samples 11 and 12 which were indistinguishable on the basis of MEE data, were able to be separated using the RAPD technique (Fig. 1) .
The clinical isolates were compared with respect to both geographical location and clinical outcome. Fig. 1 depicts two major clusters occurring within the isolates. These isolates do not appear to be grouped according to the geographical location of the isolates, although the majority of one cluster contains isolates from an island community, while the other cluster contains the majority of the isolates obtained from rural Queensland centres. If the RAPD results are analysed on the basis of disease Fig. 1 . B. pseudomallei isolates : dendrogram demonstrating relatedness by RAPD analysis. Isolates obtained from cases 1^18. Individual case details are given in Table 1. state, patients presenting with pneumonia symptoms cluster together, as do patients presenting with soft tissue abscesses. Isolates 1 and 2 which cluster together were geographically isolated, however both cases su¡ered from neurological disease and were fatal.
Multilocus enzyme electrophoresis (MEE) analysis
A total of 10 enzymes as listed in Table 2 were used to type the B. pseudomallei isolates. These produced nine distinct electrophoretic types, with samples 11 and 12 being indistinguishable. Three clusters could be distinguished with MEE, which related to the distribution patterns observed with the RAPD data.
Discussion
In common with most infective organisms, the pathogenicity of B. pseudomallei is related to both host and organism factors. Host risk factors for clinical disease in Northern Australia have been well described and include male sex, Aboriginality, diabetes mellitus, alcohol abuse and an outdoor occupation [11, 12] . A number of features of the organism have been shown to correlate with pathogenicity. One of these is toxin production. Cytolethal toxin (CLT) has been identi¢ed from culture ¢ltrates of B. pseudomallei [13] . Its mechanism of action is unknown although its rapidity of action would suggest that it could act directly on the cell membrane. Soil isolates have been found to be least cytolethal while those from severely ill patients with encephalitis caused by B. pseudomallei were the most active. Upregulation of this toxin may occur during passage through animals and humans [13] .
A recent study looking at diferences between clinical and environmental isolates showed that two groups of ribotype patterns were found. Group I consisted of both clinical and environmental isolates while Group II had only environmental strains. It was further demonstrated that all but one of the Group II isolates were able to utilise L-arabinose. This was in contrast to the Group I isolates of which only 3% could utilise this sugar as their sole energy source [14] . The signi¢cance of this ¢nding is unknown but it may be a potential marker of pathogenicity.
Epidemiological investigations are highly dependent on the reliability and reproducibility of typing systems able to di¡erentiate between isolates, and isolates from di¡erent sources. No single typing method is adequate for typing organisms. Ideally, two or three methods should be used, producing comparable results. The choice of a typing method is dictated by cost, ease of use and reproducibility.
Several studies have compared di¡erent typing methods for Listeria monocytogenes [15] , Enterobacter cloacae [16] and Neisseria meningitidis [17] . The investigators carrying out these studies have differed in their opinion of which particular typing method is the more discriminatory. It may be that di¡erent typing methods are more suited to some organisms than others. The results of this study indicate that although both MEE and RAPD assays were highly discriminatory for B. pseudomallei isolates, RAPD was able to di¡erentiate between two isolates found to be identical with MEE (cases 11 and 12). Although the stimulus to this study was to investigate the possibility that there was an epidemiological link between the cases of melioidosis which occurred at the same period of time in four di¡erent locations in North Queensland after some years of quiescence in the incidence of the disease, the results from this typing study indicated that the isolates tested, clustered on the basis of disease presentation, rather than by geographical location. Two broad groups are seen based on the relatedness of the isolates as de¢ned by the RAPD and MEE analysis. Cases 1^9 which formed the ¢rst group consist mainly of patients with respiratory disease. It also includes two children who had brain stem encephalitis (cases 1 and 2) and case 3 in whom no clinical source of sepsis could be determined. The second group (cases 10^18) consist of isolates from patients with abscesses in viscera other than lung or brain, and from patients with bone and joint disease. This ¢nding represents an interesting development not previously described. These results suggest that B. pseudomallei may carry genetic regions capable of in£uencing tissue tropism of the infecting strain and thus contributing to the particular manifestation of melioidosis in the patient infected with that particular strain. The contribution of genetically de¢ned microbial virulence factors to the manifestation of infection with organisms that vary in their expression of virulence factors, is well recognised in infectious diseases. Examples include the variable expression of exotoxin by the group A streptococcus and its role in generating streptococcal toxic shock syndrome, the presence of the lysogenic beta prophage in strains of Corynebacterium diphtheriae that cause clinical diphtheria and the contribution of various genetically de¢ned virulence determinants in strains of Escherichia coli to the di¡erences in the forms of gastroenteritis caused by this bacterial species. The variation in the presentation of melioidosis is well recognised though the determinants of this have not as yet been identi¢ed. They would logically include both host and microbial factors. This study suggests di¡erences in the patterns of disease caused by genetically clustered isolates of B. pseudomallei, and may point the way to identifying microbial factors that contribute to how infection with this organism expresses itself. These ¢ndings clearly need to be examined in a prospective study with a larger group of clinical isolates. A comparison of clonality between clinical isolates and environmental isolates obtained during the same period, would also help in the development of this clonal hypothesis.
The use of other typing methods such as pulsed ¢eld gel electrophoresis (PFGE) along with the techniques used in this study would add greater reliability and discrimination. If clonality with B. pseudomallei is shown to be related to disease process, it would be a signi¢cant advance in our understanding of the pathogenesis of melioidosis.
